Special Warning : אזהרת שימוש

4.4 Special warnings and precautions for use
Sodium chloride 0.9 % Imuna should be used with caution only in - hypokalaemia
- hypernatraemia
- hyperchloraemia
- Conditions requiring a restricted intake of sodium, such as heart failure, generalised oedema, pulmonary oedema, hypertension, eclampsia and severe renal failure.

In order to prevent osmotic demyelination syndrome from developing, serum sodium concentrations should not exceed 9 mmol/L/day. As a general recommendation, a rate of correction of 4 to 6 mmol/L/day is considered appropriate in the majority of cases, depending on the patient's conditions and associated risk factors.

Clinical monitoring should include checks of the serum ionogram, water balance and the acid-base balance.

If the rapid infusion of 0.9 % NaCl is required, the cardiovascular and respiratory status should be monitored closely.

Please note: if this solution is being used as a carrier solution, the safety information on the additive provided by the respective manufacturer is to be taken into account.

Children and adolescents

Premature or newborn babies may develop excess sodium levels due to immature kidney function.
Therefore, repeated sodium chloride infusions should only be administered after serum sodium levels have been determined.

Effects on Driving

4.7 Effects on ability to drive and use machines
Sodium chloride 0.9 % Imuna has no or negligible influence on the ability to drive and use machines.